Key Metrics
CiteScore 

16.2
Eigenfactor 

0.01 - 0.05
H-Index 

130
Impact Factor 

10 - 15
Scite Index 

0.95 5-Year SI

SJR 

Q1Molecular Medicine

SNIP 

2.15
Recommended pre-submission checks
Powered by 

Topics Covered on EMBO Molecular Medicine
EMBO Molecular Medicine Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 5000 | GBP 3960 | EUR 4500 |
| Publication Time | 26 |
| Editorial Review Process | Anonymous peer review,Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | EMBO |
| Frequency | Monthly |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review,Double anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in EMBO Molecular Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in EMBO Molecular Medicine
Disease-stage-specific immunometabolic remodeling in pediatric obstructive sleep apnea: a single-cell transcriptomic atlas of adenoid tissue
- 27 Apr 2026
- EMBO Molecular Medicine
Systemic delivery of AAV-GFM1 corrects COXPD1 molecular alterations in Gfm1R671C/- mice.
- 17 Apr 2026
- EMBO molecular medicine
Pharmacological targeting of the NLRP3 LRR domain with isothiazolinones overcomes CRID3-resistant inflammation.
- 17 Apr 2026
- EMBO molecular medicine
Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.
- 17 Apr 2026
- EMBO molecular medicine
Organelle resilience as a comparative blueprint for longevity.
- 16 Apr 2026
- EMBO molecular medicine
Hypothalamic regulation of sepsis-associated anorexia: cytokine and hormonal signalling through AgRP/POMC circuits.
- 15 Apr 2026
- EMBO molecular medicine
Disease-stage-specific immunometabolic remodeling in pediatric obstructive sleep apnea: a single-cell transcriptomic atlas of adenoid tissue
- 27 Apr 2026
- EMBO Molecular Medicine
Systemic delivery of AAV-GFM1 corrects COXPD1 molecular alterations in Gfm1R671C/- mice.
- 17 Apr 2026
- EMBO molecular medicine
Pharmacological targeting of the NLRP3 LRR domain with isothiazolinones overcomes CRID3-resistant inflammation.
- 17 Apr 2026
- EMBO molecular medicine
Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.
- 17 Apr 2026
- EMBO molecular medicine
Organelle resilience as a comparative blueprint for longevity.
- 16 Apr 2026
- EMBO molecular medicine
Hypothalamic regulation of sepsis-associated anorexia: cytokine and hormonal signalling through AgRP/POMC circuits.
- 15 Apr 2026
- EMBO molecular medicine